(Exact name of small business issuer as specified in its charter)
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
(Address of principal executive offices)
(Registrant's Telephone number)
(Former Name or Former Address, if Changed Since Last Report)
On March 1, 2012, the Board of Directors of QuantRx Biomedical Corporation (the "Company") appointed Michael S. Abrams, 42, to its Board of Directors to serve until the next annual meeting of shareholders or until his successor is elected and nominated. Mr. Abrams is currently a Managing Director of Burnham Hill Partners, LLC, a New York-based investment and merchant banking firm, which he joined in August of 2003. Mr. Abrams is also the Chief Financial Officer and a Director of Bond Laboratories, Inc., an Omaha, Nebraska based national provider of innovative and proprietary nutritional supplements for health conscious customers. Mr. Abrams holds a Master of Business Administration with Honors from the Booth School of Business at the University of Chicago. Prior to his graduate studies, Mr. Abrams received his BBA with Honors from the University of Massachusetts at Amherst as a William F. Field Alumni Scholar, where he graduated ranked first in the area of Finance.
There are no arrangements or understandings between Mr. Abrams and any other persons, naming such persons, pursuant to which Mr. Abrams was selected as a director of the Company.
QuantRx Biomedical Corporation |
By: | /s/ Shalom Hirshman |
Name: Shalom Hirshman | |
Title: Chief Executive Officer |